Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
Molecular targets of FTY720 (fingolimod).
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
Mapi Pharma Receives Additional Claims for Its U.S. Patent for Glatiramer Acetate Depot for the Treatment of Multiple Sclerosis
Epstein-Barr virus: an important vaccine target for cancer prevention.
Keystone Symposium on Growing to Extremes: Cell Biology and Pathology of Axons
Positive year one results from Biogen Idec's Phase 3 advance trial of PLEGRIDY™ (peginterferon beta-1a) presented at AAN meeting
Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain. Reply].
"Tell me what you want, what you really really want….": asking people with multiple sclerosis about enhancing their participation in physical activity.
Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.
Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.
Potassium-Retaining Diuretics: Amiloride
A comparative study of experimental mouse models of central nervous system demyelination.
Assessment of the effect of interferon-beta1a therapy on thyroid and salivary gland functions in patients with multiple sclerosis using quantitative salivary gland scintigraphyz.
Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
Medical marijuana: clearing away the smoke.
Review of subcutaneous interferon β-1a, delivered via the electronic self-injection device RebiSmart™, for the treatment of multiple sclerosis.
Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.

Pages